Thromboinflammation and the hypercoagulability of COVID-19.
作者信息
Connors Jean M, Levy Jerrold H
机构信息
Department of Medicine, Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Departments of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC, USA.
出版信息
J Thromb Haemost. 2020 Jul;18(7):1559-1561. doi: 10.1111/jth.14849. Epub 2020 May 26.
Abstract
摘要
相似文献
1
Thromboinflammation and the hypercoagulability of COVID-19.新冠病毒感染的血栓炎症与高凝状态
J Thromb Haemost. 2020 Jul;18(7):1559-1561. doi: 10.1111/jth.14849. Epub 2020 May 26.
2
COVID-19 and hypercoagulability in the outpatient setting.门诊环境中的2019冠状病毒病与高凝状态
Thromb Res. 2020 Aug;192:122-123. doi: 10.1016/j.thromres.2020.05.031. Epub 2020 May 23.
3
Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill.新冠肺炎危重症患者血栓弹力图结果与高凝综合征。
JAMA Netw Open. 2020 Jun 1;3(6):e2011192. doi: 10.1001/jamanetworkopen.2020.11192.
4
Hypercoagulability and coronavirus disease 2019-associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms.高凝状态与2019冠状病毒病相关的低氧性呼吸衰竭：机制与新出现的管理模式
J Trauma Acute Care Surg. 2020 Dec;89(6):e177-e181. doi: 10.1097/TA.0000000000002938.
5
Selective inhibition of thromboinflammation in COVID-19 by Btk inhibitors.布鲁顿酪氨酸激酶（Btk）抑制剂对新冠病毒病血栓炎症的选择性抑制作用
Platelets. 2020 Nov 16;31(8):989-992. doi: 10.1080/09537104.2020.1809647. Epub 2020 Sep 6.
6
A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors.使用布鲁顿酪氨酸激酶（Btk）抑制剂阻断新冠病毒病血栓炎症反应的理论依据。
Platelets. 2020 Jul 3;31(5):685-690. doi: 10.1080/09537104.2020.1775189. Epub 2020 Jun 19.
7
Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability.危重症新型冠状病毒肺炎感染患者表现出与高凝状态一致的凝血波形分析参数增加。
Am J Hematol. 2020 Jul;95(7):E156-E158. doi: 10.1002/ajh.25822. Epub 2020 May 4.
8
Update: Venous Thrombosis and Hypercoagulability in the Abdomen and Pelvis-Findings in COVID-19.更新：COVID-19 中腹部和骨盆的静脉血栓形成和高凝状态-发现。
Radiographics. 2020 Sep-Oct;40(5):E24-E28. doi: 10.1148/rg.2020200119. Epub 2020 Jul 10.
9
Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy.纤维蛋白溶解抵抗：新冠病毒感染相关凝血障碍的潜在机制
Thromb Haemost. 2020 Sep;120(9):1343-1345. doi: 10.1055/s-0040-1713637. Epub 2020 Jul 9.
10
The Role of Anticoagulation in COVID-19-Induced Hypercoagulability.抗凝在 COVID-19 诱导的高凝状态中的作用。
Curr Cardiol Rep. 2020 Jun 17;22(7):53. doi: 10.1007/s11886-020-01328-8.
引用本文的文献
1
Thromboembolic safety and clinical benefits of tranexamic acid beyond hemostasis in post-COVID-19 patients undergoing major arthroplasty: A STROBE-compliant retrospective study.氨甲环酸在新冠后接受大关节置换术患者中的血栓栓塞安全性及止血以外的临床益处：一项符合STROBE标准的回顾性研究
Medicine (Baltimore). 2025 Sep 5;104(36):e44317. doi: 10.1097/MD.0000000000044317.
2
Etiology and Risk Factors for Splanchnic Vein Thrombosis in Non-Cirrhotic, Non-Neoplastic Patients: A Narrative Review.非肝硬化、非肿瘤患者内脏静脉血栓形成的病因及危险因素：一项叙述性综述
Medicina (Kaunas). 2025 May 21;61(5):933. doi: 10.3390/medicina61050933.
3
Patterns of Prophylactic Anticoagulation Among Patients Hospitalized for COVID-19: An Analysis of the American Heart Association COVID-19 Cardiovascular Disease Registry.COVID-19住院患者预防性抗凝治疗模式：美国心脏协会COVID-19心血管疾病登记研究分析
J Am Heart Assoc. 2025 Mar 4;14(5):e034186. doi: 10.1161/JAHA.123.034186. Epub 2025 Mar 3.
4
COVID-19's effects on microvascular structure in a healthy retina: an OCTA study.COVID-19对健康视网膜微血管结构的影响：一项光学相干断层扫描血管造影（OCTA）研究
Int J Ophthalmol. 2025 Feb 18;18(2):283-289. doi: 10.18240/ijo.2025.02.12. eCollection 2025.
5
Facial Nerve Palsy Amid the SARS-CoV-2 Pandemic: A Pooled Analysis.2019冠状病毒病大流行期间的面神经麻痹：一项汇总分析
J Otolaryngol Head Neck Surg. 2025 Jan-Dec;54:19160216251315057. doi: 10.1177/19160216251315057.
6
The Impact of Deep Local Lung Hyperthermia on COVID-19 Cancer Patients.深部局部肺部热疗对新冠癌症患者的影响
Adv Biomed Res. 2024 Oct 28;13:92. doi: 10.4103/abr.abr_75_23. eCollection 2024.
7
Pathological Sequelae of SARS-CoV-2: A Review for Clinicians.新型冠状病毒2019冠状病毒病的病理后遗症：临床医生综述
Yale J Biol Med. 2024 Dec 19;97(4):431-445. doi: 10.59249/DQJH2274. eCollection 2024 Dec.
8
Cushing's syndrome and COVID-19.库欣综合征与新型冠状病毒肺炎
Pituitary. 2024 Dec;27(6):945-954. doi: 10.1007/s11102-024-01466-0. Epub 2024 Nov 14.
9
Detached epithelial cell plugs from the upper respiratory tract favour distal lung injury in Golden Syrian hamsters (Mesocricetus auratus) when experimentally infected with the A.2 Brazilian SARS-CoV-2 strain.从上呼吸道脱落的上皮细胞塞有利于金黄地鼠（Mesocricetus auratus）在实验感染 A.2 巴西 SARS-CoV-2 株时远端肺部损伤。
Mem Inst Oswaldo Cruz. 2024 Oct 21;119:e240100. doi: 10.1590/0074-02760240100. eCollection 2024.
10
American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary.美国血液学会关于COVID-19患者血栓预防抗凝治疗的实用指南：执行摘要
Blood Adv. 2025 Mar 25;9(6):1247-1260. doi: 10.1182/bloodadvances.2024014219.
本文引用的文献
1
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.COVID-19 急性呼吸窘迫综合征患者的促凝模式。
J Thromb Haemost. 2020 Jul;18(7):1747-1751. doi: 10.1111/jth.14854. Epub 2020 May 6.
2
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
3
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.新型冠状病毒肺炎重型患者静脉血栓栓塞症发病情况。
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.
4
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
5
Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia.2019新型冠状病毒肺炎患者的弥散性血管内凝血
J Thromb Haemost. 2020 Apr;18(4):786-787. doi: 10.1111/jth.14781. Epub 2020 Mar 24.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
8
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
9
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
10
Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation.脓毒症诱导的凝血病和弥散性血管内凝血的诊断与管理
J Thromb Haemost. 2019 Nov;17(11):1989-1994. doi: 10.1111/jth.14578. Epub 2019 Aug 13.
Zotero 插件